Et tu brutus?! selling calls options higher than 15 price target? Did I say too much?
the price of the trades dictates where this is going, it justifies my explanation. I am not overzealous like many longs. Of course, I would love to see $50/sh as you people pump but I am not a pumper, I am realist. I will be happy with $12-15/sh buyout which seems to justify the lack of short coverage.
are you trying to convince investors into buying your 15 and higher calls options? Did I say too much? LOL
unlike you, I don't try to sucker investors into buying my options which will all expire worthless in a couple of months. Did I say too much there?
you have a better explanation for what has transpired? Look at all the facts around you and come up with one explanation that best suits all your facts. Buyout at $4-6 billion, not enough to scare short coverage.
Looking at the trading patern and silence of the company, with the volume of shorts unchanged since FDA approval suggest that this is a buyout. Unfortunately, the selling price isn't that much. My guess is somewhere around $4-6 bil which would put the pps around 10-15. Some of the shorts knew this already but they don't know the exact determined price; that is the reason why the shorts have not covered. Why cover when it is only a couple of bucks off (or it could be $4 bil, which would put pps at $10-11). If they start covering for expected buyout price, let's say $15/sh, they could generate a massive short coverage rally that could go to $20. The problem is that at $20, Mankind may back out of the buyout, and instead Alfred Mann may decide to sell his shares at $20 instead of buyout at $15.
What mnkd is doing now is remaining in silence, sad to say but I have to agree with some of the shorts theory here, that Alfred Mann, may be doing some insiders tradings. A. Mann may be accumulating cheaper shares in order to make profits. But I am going to hold on to all my shares because I don't think they would sell Afrezza and Technosphere for less than $4 bil. 20% profit is all I am hoping for (buyout at $4-6 bil)
another way Mann can make money is write long term options, only he knows how much the company is sold for. Therefore, I am holding all my shares and will only addd more on dips. I think it is worth more than $5 bil. I am almost 100% certain this is a buyout.
OMG! they only covered about 2 mil shares after FDA approval? Wow! This thing will shoot straight up to the moon on any good news. $30-50, and will trade without any technicals, on fear alone!
girls don't like short stumps. What do you think the buyout price is? Please no dreamers or bashers, post only reasonable price for buyout. Hopefully some can supply some numbers of expected sales etc.
i guess I am the only one who understood your direction. I am a newby here, stood in the sideline til approval, bought at 11 yesterday but wishing now I waited til today but can't be super accurate on everything.
My answer,even patients who do't rely on insulin can still use Afrezza to control post meals hyperglycemia. Simply, after a huge meal, even when you are still producing adequate insulin, the post meal requirement is much larger than your baseline, Afrezza can become gold standard for ALL diabetics to for tighter glucose control.
if you were live infront of me, I would take a hair tweezer and snip your manhood off in one move.
If it hadn't been for their headfake on Friday that momentarily took the pps down to 9, this baby could be rallying in mid teens now. But that sudden selloff got investors on their seats, now even longs are uneasy about the short's ability to manipulate the market.
I wish that Alfred Mann has a retaliation for these azsholes, sell it at $35/sh Mr. Mann. They wouldn't know what hit them. Bam! dead on contact, like a littel bug on the windshield at 80 mph. I will then scrape off their genitals and feed them to the dogs.
sales reps are sometimes recruited way before the drug is out. They get trained on the drugs and ways to sell them. Hiring positions posted months ahead, etc. I wouldn't be surprised if the general info is given to the sales rep but they don't quite yet know the name, to keep confidentiality.
With Adcom vote of 27 to 1 on approval, we already know that the chance of approval is very high. Thus, to bet on shorts is like placing your money on green on a Roullette table; you can get it but the odds is very low and your chance of loss is unlimited. STrategically not wise to hold a short postion going into this binary event, so why do it?
So why hold through this binary event? I personally think they will throw the white flag in soon before July 15th; no body wants to be the last short to cover. If they don't cover before the binary event, they would have to hedge it by buying calls. Or these hedge fund managers are using their clients' money to short the stock, yet the managers themselves are buying shares/calls for themselves; hence, when they cover, the rally will benefit their personal accounts but the losses are coming out of their clients' accounts.
1) FDA approval
3) Media frenzy after approval
4) Stock Manipulation on a heavy shorted volume.
agree, when they do cover, their calls is probably worth more than their losses in short positions. That's one way of doing it! I may hedge too
potential partners: Eli Lilly, Novo Nordisc, and J&J. These companies have significant incomes from insulin and they may see a huge threat from Afrezza. Look for them to make a bid.
I don't think Pfizer is interested, despite rumors, because if you look at pfizer business model, they are quite nonrisk, most high selling drugs. They may try to buy out afrezza once marketed (if they have outstanding sales record) but not at this stage.
When shorted shares reaches optimal level, there isn't any more free shares left to short, facing huge company event where there is high demand for shares but no sellers are willing to relinguish shares. Thus, sending the share price sky high due to high demands from both buyers and shorters looking to buy back and cover their shorted shares.